Member Info for dafad

So if schools are going to test pupils,then surely they will not be using the test my partner is due to recieve tomorrow

My partner who is a primary school teacher in wales has tonight been told that she will have to take a test at home every Sunday and Wednesday night and then record the result on some goverment website immediately afterwards,She has been told that the test will take approx 30 minutes to get the results.She is due to get the testing kit tomorrow

@16.31 on adv.. site

Showing as sell at 100p

Might be a mistake as both exact same time

.

Managed Access: Net revenue flat at £12.7m (2019: £12.7m) with the impact of COVID-19 being offset by an increase in the number of MAP wins for H1 versus H1 2019 and the contribution from programs signed in FY20.

As at 31 December 2020, there were 149 individual product MAPs (Dec 2019: 118, June 2020: 131), including products in the COVID-19 space such as Synairgen's SNG001 program for the treatment of hospitalised patients with COVID-19. Collectively, the top 10 MAPs contributed 28% of the Managed Access gross profit (Dec 2019: 34%, June 2020: 38%).

Sorry if posted,been busy last couple of weeks

https://directorsblog.nih.gov/2021/02/16/activ-update-making-major-strides-in-covid-19-therapeutic-development/

4th Rig on the way!!

Mon, 22nd Feb 2021 07:00

RNS Number : 8115P
Orosur Mining Inc
22 February 2021



Orosur Mining Inc - Colombia update



· Assays from four additional holes

· High grade gold intersections - 21.6m @ 6.02g/t Au, 12.25m @ 5.39g/t Au and 4.35m @ 2.53g/t Au.

· Polymetallic nature confirmed with high grade Zinc intersection of 19.85m @ 6.46% Zn and 21.60m @ 3.23%Zn, with minor Copper up to 0.8%.

· 4th rig to mobilise



London, February 22nd, 2021. Orosur Mining Inc. ("Orosur" or the "Company") (TSX/AIM:OMI), is pleased to announce an update on the progress of Minera Anzá's drilling campaign currently underway at the Company's Anzá project in Colombia.



To view the full PDF version of the announcement with Figures 1-3 included, please refer to this link: http://www.rns-pdf.londonstockexchange.com/rns/8115P_1-2021-2-21.pdf



Results of further four holes.

Diamond drill holes MAP-073, 074, 075 and 076 were completed during December 2020 and January 2021, with the holes positioned largely to address geological questions that were left unanswered from older drilling campaigns by previous companies.



Over 18,000m was drilled by Waymar Resources prior to it becoming part of Orosur in late 2014. Subsequent work by Orosur determined that much of this older drilling was oriented down dip, and while these holes often returned superficially attractive assay results, they did not provide sufficiently reliable geological information to fully understand the nature of the mineralisation and to allow accurate targeting and efficient expansion drilling.



As a result, much of the Company's initial 2,300m drill program currently underway, was designed to answer several outstanding orientation and structural questions and to provide insight into the style of mineralisation, with a focus on the potential for a hybrid polymetallic VMS/Epithermal model.



These four holes were drilled on three sections, and returned attractive gold intersections, assisted in addressing key structural questions, and returned wide intersections of high-grade Zinc that added weight to the polymetallic VMS model. Key intersections include (full intercepts are detailed in table 1):





MAP-073 21.60m @ 6.02g/t Au, 6.02g/t Ag and 3.23 %Zn from 271.75m

MAP-074 5.20m @ 1.17g/t Au 4.97g/t Ag and 3.02% Zn from 195.40m

MAP-075 19.85m @ 0.90g/t Au 2.17 g/t Ag and 6.46% Zn from 226.15m

MAP-076 12.25m @ 5.39g/t Au, 1.65 g/t Ag and 0.18 % Zn from 228.65m

For me it will be very interesting to see who Dvrg have managed to bag in order to promote the Skin brand.these so called Influencers carry some power in the modern world

Gerard J Brandon
@gjbrandon
Replying to
@champers84

@skintrustclub
and 2 others
There is an entire PR program across 3 continents which involve everything from MSM to influencers

The initial wholesale order of 10,000 units has been received by MGC Pharma, which has a total retail market value of US$850,000 for Swiss PharmaCan AG.

So it has a total RETAIL value for Swiss Pharma of $850,000-does anyone know how much we get for the 10,000 units WHOLESALE

Sibanye-Stillwater Ltd. on Thursday reported a record high profit for 2020, as it benefited from strong precious metal prices and a weaker South African rand.

The Johannesburg- and New York-listed mining company made a net profit of $1.78 billion in 2020, the highest for any year since it was formed in 2013, according to FactSet, and up from $4.5 million in 2019. Sibanye-Stillwater had forecast net profit at between $1.75 billion and $1.82 billion.

Adjusted earnings before interest, taxes, depreciation, and amortization rose threefold to $3.00 billion from $1.03 billion, and revenue increased to $7.74 billion from $5.04 billion.

"Despite the significant challenges associated with the Covid-19 pandemic, the group delivered a record financial performance and made notable progress towards delivery on many strategic targets," Chief Executive Neal Froneman said.

Sibanye-Stillwater last month had reported a 83% surge in its average platinum, palladium, rhodium and gold basket price for 2020, combined with a 14% depreciation of the rand against the dollar.

The company declared a final dividend of 88.8 cents a share.

about the breathtest

17/02/2021 7:00am
UK Regulatory (RNS & others)

Deepverge (LSE:DVRG)
Intraday Stock Chart

Wednesday 17 February 2021

Click Here for more Deepverge Charts.
TIDMDVRG

RNS Number : 2989P

Deepverge PLC

17 February 2021

17 February 2021

DeepVerge PLC

("DeepVerge" or "the Company")

DeepVerge production orders worth $5m (GBP3.6m) for Modern Water equipment in Q1

8 Modern Water units being retrofitted with MicrotoxPD SARS-CoV-2 wastewater detection systems

Manufacturing being implemented to increase our production capacity in China in Q2

DeepVerge (LSE:DVRG.L), the environmental and life science AI company, announces that since the offer for the acquisition of Modern Water plc was completed on November 17, 2020, contractual obligations have been signed for the production of water contamination equipment worth $5 million USD (GBP3.6m) to meet its obligations with distributors and customers. Notably, 80% of the equipment being produced is earmarked for the Chinese market, where further assembly and localization will be carried out. These orders are expected to be delivered during the current financial year ending 31 December 2021.

-- Instruments from across the range of Microtox and Microtrace are being manufactured with upgrades to the software allowing optimised collection and organisation of data for real time surveillance.

-- Screens have been upgraded with Chinese interfaces across the range of Modern Water's ("MW") bench top lab equipment.

-- This month over 100 of the 2019 Award Winning [i] Microtox bench top and mobile instruments are completing production for immediate delivery.

-- 40 Handheld trace metal detector PDVs [ii] have been manufactured to meet immediate obligations and a significant upgrade design is underway on a further 100 units to be produced.

-- Big ticket (c$50,000 USD) online monitors from the Microtox CTM [iii] toxicity range and the Microtrace metal OVA [iv] range are being produced across two sites with 40 units scheduled for final assembly at our Shanghai, China, facilities in March.

-- 8 MW, Microtrace OVA, units are being retrofitted with the MicrotoxPD [v] real-time optofluidic COVID detection system for wastewater.

-- Upgrade to the MW reagent production line, in York, UK, being completed with the installation of a HS-2 Freeze Drying Lyophilizer from Frozen in Time [vi] . This streamlines downstream processing, automates quality control, improving volume output of the recurring revenue consumables used by most of the MW range of equipment.

-- Microsaic's in-line bio-processing monitoring unit [vii] , announced in the RNS [viii] of the 15th of February, will fully automate the upstream quality control system removing all manual testing requirements.

Phase two of our manufacturing plan is being implemented to increase manufacturing capacity in China in Quarter 2, 2021 to double current capacity by year end.

Gerard Brandon, CEO of DeepVerge plc, commented:

Just gone through-news on the way!!

https://twitter.com/OrosurMining/status/1361341491025764354

5/02/2021 7:00am
UK Regulatory (RNS & others)

Synairgen (LSE:SNG)
Intraday Stock Chart

Monday 15 February 2021

Click Here for more Synairgen Charts.
TIDMSNG

RNS Number : 0247P

Synairgen plc

15 February 2021

Press release

Synairgen plc

('Synairgen' or the 'Company')

Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatients

Southampton, UK - 15 February 2021: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces that dosing has begun in the inhaled interferon beta formulation (SNG001) sub-study of the ACTIV-2 Phase II/III trial, evaluating patients with mild to moderate COVID-19 symptoms not yet requiring hospitalisation.

Richard Marsden, CEO of Synairgen, said: "We are delighted that our inhaled interferon beta formulation has been entered into this US Government-funded Phase II/III study and that dosing has now commenced. With mutations of COVID-19 now emerging, and the concern that mutations may render the vaccines less effective, the need for broad spectrum treatment options remains very high. Our product is a potentially effective treatment as it is a virus agnostic and, we believe, strain agnostic antiviral, which is easy to use in the hospital or home setting. We look forward to tracking the progress of the ACTIV-2 trial alongside our other COVID-19 trials."

As announced by Synairgen on 25 January 2021, ACTIV is a public-private partnership to develop a coordinated research strategy to speed up the development of the most promising COVID-19 treatments and vaccines. ACTIV-2 is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, and is led by the NIAID-funded AIDS Clinical Trials Group (ACTG).

If an investigational agent shows promise by demonstrating safety and reducing COVD-19 symptoms through 28 days following administration, the ACTIV-2 trial is designed to expand seamlessly from a Phase II to a Phase III study to gather additional critical data from a larger pool of volunteers without delay. Phase II sub-studies enrol up to 220 volunteers, while exact enrolment size of Phase III sub-studies will vary depending on mode of administration of the investigational agent. The adaptive nature of the ACTIV-2 trial allows for comparison of multiple interventions with a shared group of placebo recipients. In addition to safety and symptomatic efficacy signals, the sub-studies in ACTIV-2 assess whether an investigational agent can reduce the amount of SARS-CoV-2 virus detectable in the nasopharynx.

For more information on the ACTIV-2 study, please visit www.riseabovecovid.org, or visit ClinicalTrials.gov and search identifier NCT04518410.

Synairgen is also running an international 610 patient Phase III trial, which is progressing well, assessing the efficacy of inhaled interferon beta in hospita

On Saturday the government will announce that the world's most innovative Covid treatments will be fast-tracked through the UK's clinical trial system.

The above is from todays Daily Mail,I wonder if they will name the Innovative treatments.If the treatments are named and Sng is not on the list then Hanc*** must GO!!!

https://www.dailymail.co.uk/news/article-9255903/Matt-Han****-hopes-treatable-virus-disease-live-like-flu.html

Looking at the CL3 lab at Liverpool with whom we have some sort of working relationship/use of their facility

https://www.youtube.com/watch?v=CioQY-6vohI

Good effort bob, but infact Dafad is an Ewe and Defaid are Sheep,lol

https://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/

ignore sorry dated Nov 12